The global nutraceutical CDMO market is on track for substantial expansion, with a projected year-over-year growth rate of 6.8%. According to recent forecasts, the market’s value is expected to surge from US$ 35,730.8 million in 2024 to an impressive US$ 61,655.3 million by 2034. This growth trajectory is underpinned by a steady demand surge, projected to increase at a compound annual growth rate (CAGR) of 5.6% over the forecast period.
Several key factors are driving this surge in the global nutraceutical CDMO market. Among them is a burgeoning demand for nutraceuticals, a trend towards outsourcing, and the rising popularity of personalized nutrition. Nutraceutical companies are increasingly turning to CDMOs for their specialized expertise, cost-saving benefits, and streamlined processes.
Request A Sample Copy of This Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-18770
The demand for nutraceutical contract development and manufacturing services is expected to escalate significantly as companies seek to optimize costs, save time, and enhance efficiency. By outsourcing research and development functions to CDMOs, leading nutraceutical firms can capitalize on specialized skills, reduce time-to-market, and drive innovation.
Nutraceutical CDMOs play a pivotal role in supporting market growth by offering tailored services designed specifically for the nutraceutical sector. These organizations collaborate with nutraceutical companies across various stages of product development and manufacturing, facilitating the launch of innovative, high-quality products to market.
With an aging population and growing awareness of cognitive health, there is a burgeoning demand for brain health supplements. Nutraceutical CDMOs are well-positioned to capitalize on this trend by developing formulations enriched with cognitive-enhancing ingredients, such as omega-3 fatty acids and antioxidants.
Furthermore, the emphasis on personalized nutrition presents new opportunities for collaboration between CDMOs and brands. By leveraging their expertise in formulation development, CDMOs can create customized products tailored to individual health needs and preferences.
Artificial intelligence (AI) technologies also hold promise for the nutraceutical CDMO market, enabling the analysis of vast datasets to inform personalized product recommendations and formulations. This integration of AI-driven solutions underscores the market’s commitment to meeting evolving consumer demands for tailored health and wellness products.
In conclusion, the global nutraceutical CDMO market is poised for significant growth, driven by factors such as increasing demand, outsourcing trends, and personalized nutrition preferences. As key players in this dynamic landscape, nutraceutical CDMOs have the opportunity to drive innovation and meet the evolving needs of consumers worldwide.
Key Takeaways from the Market Study:
- The global market for nutraceutical CDMOs is set to reach a valuation of US$ 61,655.3 million in 2034.
- By dosage form, the tablets & capsules segment held a share value of 1% in 2023.
- By services, the manufacturing and packaging segment accounted for a market value share of 1% in 2023.
- By company size, the mid-sized companies segment is poised to grow at 7% CAGR.
- North America accounted for a substantial value share of 5% in 2023.
- Demand in China is projected to increase at 4% CAGR through 2034.
“Increasing demand for nutraceutical products globally and rising interest in personalized nutrition are expected to play key roles in boosting the nutraceutical CDMO market growth through 2034,” says an analyst of Future Market Insights (FMI).
Request Methodology Now: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-18770
Who is Winning?
Nutraceutical CDMOs are collaborating with brands to share expertise in personalized product development. By working closely with clients, CDMOs can contribute insights into ingredient selection, dosages, and formulation strategies that align with the emerging trends in self-care and personalization. Several companies are also employing strategies like acquisitions and partnerships to stay ahead of the competition.
Recent Developments:
- In June 2022, Best Formulations, a leading company specializing in the production of nutraceuticals and dietary supplements, completed the acquisition of Sirio, a global nutraceuticals contract manufacturer renowned for its expertise in the supplement market. The acquisition positions Best Formulations as a more comprehensive and diversified player in the nutraceutical contract manufacturing landscape, poised to deliver a wider range of innovative and high-quality products to clients on a global scale.
- In August 2021, Catalent, Inc. announced the acquisition of Bettera Holdings, LLC, to expand its expertise and offerings in the nutraceuticals sector.
Key Companies Profiled:
- Catalent
- Lonza
- Aenova Group
- Akums Drugs and Pharmaceutical Ltd.
- BASF SE
- Sirio Pharma
- Pharmavite LLC
- Nature’s Products, Inc.
- PLT Health Solutions
- Glanbia Nutritionals
- Recipharm AB
- B&D Nutritional Ingredients
- NutraScience Labs
- Vitakem Nutraceutical Inc.
- Softigel (A division of Procaps Group)
- Iprona AG
- Nutrilo GmbH
- Atlantic Essential Products, Inc.
- ProTec Nutra Ltd.
- Nutraceuticals International Group
Key Market Segments Covered in Nutraceutical CDMO Market Research:
By Dosage Form:
- Tablets & Capsules
- Powder
- Softgel
- Liquid Formulations
- Others (Gummies, Sprays, Sachets, Topical Forms)
By Services:
- Product Formulation and Development
- Manufacturing and Packaging
- Research and Development
- Analytical and Testing Services
- Regulatory Support
By Company Size:
- Small Companies
- Mid-sized Companies
- Large Companies
By Region:
- North America
- Latin America
- East Asia
- South Asia & Pacific
- Western Europe
- Eastern Europe
- Middle East & Africa
Get Exclusive Purchase Now to Access Strategic Intelligence: https://www.futuremarketinsights.com/checkout/18770
Have a Look at the Top Reports of the Healthcare Domain in FMI:
CMO/CDMO Market Analysis in Brazil is expected to surge at a CAGR of 2.7% in the forecast period 2023 to 2033. Its value is projected to increase from US$ 697.93 million in 2023 to US$ 907.67 million by 2033.
Liquid Filled Capsule Market is expected to rise at a CAGR of 2.9% in the forecast period 2024 to 2034. The market value is projected to increase from US$ 1,587.1 million in 2024 to US$ 2,113.9 million in 2034.
Inhalation CDMO Market is expected to expand at a CAGR of 6.4% in the forecast period 2024 to 2034. The market value is projected to increase from US$ 2,018.0 million in 2024 to US$ 3,740.2 million in 2034.
Self-administered Parenteral Market size is expected to rise from US$ 25,339.7 million in 2024 to US$ 40,598.9 million by 2034.
Small Molecule CMO/CDMO Market size is expected to register a CAGR of 5.2% during the forecast period. The market value is projected to increase from US$ 74,998.1 million in 2024 to US$ 124,532.4 million by 2034
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and market trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
